PALO ALTO, Calif., April 3 /PRNewswire/ -- Cell Biosciences announces the introduction of the Firefly(TM) 3000 automated blotless immunoassay workstation for quantitative measurement of cell signaling and protein expression. The Firefly system is designed to leverage the knowledge and intuition of life science researchers by introducing automated parallel analysis into their laboratory operations. The heart of the Firefly system is a 96 capillary automated electrophoresis system that is optimized for isoelectric focusing. The Firefly system can perform virtually all tasks from loading the sample, immobilizing proteins, probing the sample with a single Antibody linked dye, and analyzing the various forms identified. With computer-controlled repeatability and round-the-clock automation, it is designed for unattended hands-off operation.
“By focusing Cell Bioscience’s research and engineering resources on the most utilized and most variable technique used in everyday labs -- the Western Blot, we’ve developed a system that automates experimentation, increases throughput, documents workflow and reduces day-to-day and person-to-person variability,” said Linda Cahill, President & CEO at Cell Biosciences. “Working with our customers and collaborators, we identified serious inefficiencies in the blotting technique itself that makes its utility dependent on the art of the technique,” added Cahill. “These inefficiencies have not been addressed by other instrumentation manufacturers. Researchers are still performing Western Blots manually, or are limited by robotic instrumentation that does not improve the technique by eliminating handling steps and errors that handling introduce into the experiment. The Firefly system reduces the number of steps from 60 to 10, loads samples by itself, captures and processes the data by itself and integrates readily into existing lab infrastructure.
The Firefly 3000 blotless immunoassay workstation is now available for demonstration and will be on display for the first time at the 97th Annual Meeting of the American Association for Cancer Research, booth #1140, to be held in Washington, DC, April 2 to April 5, 2006.
About Cell Biosciences
Cell Biosciences is a provider of life science instrumentation for protein measurement and identification. The Company designs, manufactures, markets and supports the nano-fluidics immunoassay platform called the Firefly(TM) 3000, providing a more powerful tool for scientific investigation in biochemistry, hematology, immunology, and oncology. The Firefly system automates and streamlines the tedious technique of Western blotting by removing the blotting step and reducing the number of handling steps substantially. Cell Biosciences is located in Palo Alto, CA and be reached by phone (650 859 1485); on its website (http://www.cellbiosciences.com) or by email (sales@cellbiosciences.com).
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are made based on management’s current expectations and beliefs. Actual results may vary from those currently anticipated based upon a number of factors. The company undertakes no obligation to release publicly any revision, which may be made to reflect events or circumstances after the date hereof.
Editor: Photo images available on request.
Cell Biosciences Inc.
CONTACT: Howard D. Goldstein of Cell Biosciences Inc., +1-650-859-1313,hgoldstein@cellbiosciences.com
Web site: http://www.cellbiosciences.com/
